Your browser doesn't support javascript.
loading
Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.
Rose, Micah; Shepherd, Jonathan; Harris, Petra; Pickett, Karen; Lord, Joanne.
Afiliação
  • Rose M; Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Alpha House, Enterprise Road, Southampton Science Park, Southampton, SO16 7NS, UK.
  • Shepherd J; Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Alpha House, Enterprise Road, Southampton Science Park, Southampton, SO16 7NS, UK. jps@southampton.ac.uk.
  • Harris P; Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Alpha House, Enterprise Road, Southampton Science Park, Southampton, SO16 7NS, UK.
  • Pickett K; Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Alpha House, Enterprise Road, Southampton Science Park, Southampton, SO16 7NS, UK.
  • Lord J; Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Alpha House, Enterprise Road, Southampton Science Park, Southampton, SO16 7NS, UK.
Pharmacoeconomics ; 36(11): 1299-1308, 2018 11.
Article em En | MEDLINE | ID: mdl-29691773

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Calcimiméticos / Hiperparatireoidismo Secundário Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment Limite: Adult / Humans Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Calcimiméticos / Hiperparatireoidismo Secundário Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment Limite: Adult / Humans Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido